What is vasculitis of the lower extremity?

What is Vasculitis in the Leg?

Vasculitis in the leg is an inflammatory condition affecting blood vessels of the lower extremities, ranging from large arteries (aorta and major branches) to medium-sized muscular arteries and small vessels (arterioles, capillaries, venules), causing symptoms from muscle pain and skin lesions to limb-threatening ischemia depending on vessel size and disease type.

Understanding Vessel Size and Disease Types

Vasculitis affecting the legs is categorized by the size of vessels involved 1, 2:

Large Vessel Vasculitis (LVV)

• Affects: Aorta and its first- and second-order branches including iliac and femoral arteries
• Main types: Giant cell arteritis (GCA) and Takayasu arteritis
• Presentation: Often presents with leg claudication, limb pain, or may be asymptomatic and discovered on imaging 2
• Age pattern: GCA typically affects patients >50 years; Takayasu affects younger patients ≤40 years 2

Medium Vessel Vasculitis (MVV)

• Affects: Main visceral arteries and their branches (femoral, popliteal arteries)
• Main types: Polyarteritis nodosa, temporal arteritis
• Also includes: Wegener's granulomatosis, Churg-Strauss syndrome, Kawasaki disease 1

Small Vessel Vasculitis

• Affects: Arterioles, capillaries, and venules in muscle and skin
• Main types: ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis), leukocytoclastic vasculitis
• Associated with: Rheumatoid arthritis, systemic lupus erythematosus, other connective tissue diseases 1, 3, 1

Clinical Presentations

Muscle-Limited Vasculitis

When vasculitis is restricted to lower limb muscles 4:

• Primary symptom: Disabling calf muscle pain
• Associated features: Fever (50% of cases), ankle arthralgia (50%), skin involvement (40%)
• Key diagnostic tool: MRI showing hyperintense signal in T2-weighted images and enhancement with gadolinium
• Histology: May show polyarteritis nodosa-type pattern (40%) or leukocytoclastic vasculitis (60%)

Skin Manifestations

Leukocytoclastic vasculitis commonly presents as 5:

• Classic finding: Palpable purpura, predominantly on lower extremities
• Other manifestations: Painful burning rash, maculopapular rash, bullae, papules, plaques, nodules, ulcers, livedo reticularis

Thromboangiitis Obliterans (Buerger's Disease)

A distinct entity that behaves like vasculitis 1:

• Typical patient: Young individuals who smoke tobacco
• Pattern: Affects arteries of all sizes (smaller distal limb arteries more than proximal) and superficial veins
• Mechanism: Arterial obliterative and thrombotic process

Diagnostic Approach

Clinical Recognition

Look for these specific features 1, 6:

• Exertional symptoms: Fatigue, aching, numbness, or pain in buttock, thigh, calf, or foot related to walking
• Rest pain: Localized to lower leg or foot, worse when recumbent
• Skin changes: Poorly healing or nonhealing wounds, distal hair loss, trophic skin changes, hypertrophic nails
• Pulse examination: Diminished or absent pulses at femoral, popliteal, dorsalis pedis, or posterior tibial sites
• Systemic features: Fever, weight loss, elevated inflammatory markers

Laboratory Testing

For ANCA-associated vasculitis 3:

• ANCA testing: Approximately 90% of small-vessel vasculitis patients are ANCA-positive (MPO or PR3)
• Inflammatory markers: Elevated C-reactive protein and erythrocyte sedimentation rate
• Important caveat: ANCA negativity does not exclude vasculitis diagnosis

Imaging Studies

MRI is the cornerstone for muscle-limited vasculitis 4:

• Shows hyperintense signal correlating with clinical activity
• Useful for guiding biopsy location
• Monitors treatment response

FDG-PET/CT for large vessel involvement 2:

• Demonstrates vessel wall inflammation
• Particularly useful when temporal artery biopsy is negative or not feasible
• Can reveal extent of disease in aorta and major branches

Tissue Diagnosis

Biopsy remains essential when feasible 4:

• Muscle biopsy for suspected muscle-limited disease
• Skin biopsy for cutaneous manifestations
• Distinguishes true vasculitis from mimics (e.g., livedoid vasculopathy)

Treatment Considerations

Corticosteroids as Foundation

For most forms of lower extremity vasculitis 4:

• Initial treatment: Corticosteroids are effective in all cases
• Relapse rate: 54% require immunosuppressive agents for relapses
• Duration: Typically requires prolonged therapy

ANCA-Associated Vasculitis

Specific treatment protocols exist 3:

• Induction: Rituximab or cyclophosphamide with glucocorticoids
• Maintenance: Rituximab preferred for relapsing disease
• Duration: Maintenance therapy typically 2 years minimum

Spontaneous Resolution

Important clinical pearl: Some cases of lower extremity vasculitis, particularly muscle-limited forms without organ involvement, may resolve spontaneously 7, 8. This is more likely in:

• Patients without typical GCA/PMR symptoms
• Medium-small vessel involvement only
• Absence of systemic organ involvement

However, do not wait for spontaneous resolution if the patient has:

• Typical cranial GCA symptoms
• Polymyalgia rheumatica features
• Positive temporal artery biopsy
• Aortic or proximal branch involvement
• Progressive symptoms or functional decline

Critical Pitfalls to Avoid

1. Don't assume all leg ulcers in rheumatoid arthritis are rheumatoid vasculitis - Consider livedoid vasculopathy, which requires different treatment (anticoagulation vs. immunosuppression) 9

2. Don't rely solely on ANCA testing - 10% of true vasculitis cases are ANCA-negative 3

3. Don't miss large vessel GCA - Traditional American College of Rheumatology criteria underperform for lower extremity large vessel involvement; supplemental imaging is essential 2

4. Don't overlook MRI for muscle symptoms - It's more sensitive than clinical examination and guides biopsy 4

5. Don't confuse with peripheral arterial disease - While atherosclerosis is the most common cause of lower extremity PAD, vasculitis must be considered when there's systemic inflammation, younger age, or atypical presentation 1, 10